CTRI/2020/09/027811
Recruiting
Phase 4
Intra lesional Vasopressin administration during Hysteroscopic Myomectomy: A randomized clinical trial.
Dr SMurali0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: N858- Other specified noninflammatory disorders of uterus
- Sponsor
- Dr SMurali
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with Type0 ,1 and 2 myoma (Submucous myoma) who are scheduled to undergo hysteroscopic myomectomy
Exclusion Criteria
- •1\. Myoma \> 5cm size
- •2\. Acute PID
- •3\. Use of preoperative GnRH agonists
- •4\. Endometrial premalignant or malignant pathologies
- •5\. Women with cardiopulmonary diseases, bleeding diathesis and renal disease.
- •6\. Patients with multiple submucous myoma.
- •7\. Hypertension.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effectiveness of Vasopressin During laparoscopic HysterectomyMyoma uteri, adenomyosisJPRN-UMIN000020396Takanohara Central Hospital80
Completed
Not Applicable
The effect of Vasopressin on decreasing time of surgeryOvarian Endometrioma.Endometriosis of ovaryIRCT2013012512262N1Tehran University of Medical Science,14
Recruiting
Not Applicable
The impact of using vasopressin at the time of removal of ovarian endometriosis cyst on a woman's egg count and endometriosis-related quality of life.ACTRN12620001327976Sydney Women's Endosurgery Centre40
Completed
Phase 3
Evaluation the effect of vasopressin in ovarian endometriosis surgeryIRCT20200925048836N1Shiraz University of Medical Sciences80
Completed
Phase 3
Sub-endometrial injection of vasopressin for invasive placentapregnancy with placenta accreta.Abdominal pregnancyO00.0IRCT20191102045310N1Tehran University of Medical Sciences60